Brexanolone: A New Treatment for Postpartum Depression
The Carlat Psychiatry Report, Volume 17, Number 1, January 2019
https://www.thecarlatreport.com/newsletter-issue/tcprv17n1/
Issue Links: Learning Objectives | Editorial Information
Topics: News of Note
Chris Aiken, MD
Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC.
Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
There is a need for rapid treatment in postpartum depression, as each month of this potentially severe condition can take a toll on infant development. That is why brexanolone (Zulresso), which was recently fast-tracked for approval by the FDA, is causing such a splash.
You can't view details of this content, please login or buy subscription here